Point of Care Diagnostics Market
Point of Care Diagnostics Market by Product (Glucose, Infectious Disease [TB, HAI, STD], Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx [RT-PCR, INAAT]), Sample (Blood, Urine), End User (Home Care, Hospitals) - Global Forecast to 2031
POINT OF CARE DIAGNOSTICS MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global point of care diagnostics market is projected to grow from USD 20.63 billion in 2026 to USD 31.46 billion by 2031, at a CAGR of 8.8% during the forecast period. The market was valued at USD 19.38 billion in 2025. The rising prevalence of chronic and infectious diseases worldwide is a major factor driving demand for POC diagnostics. Patients with conditions such as diabetes, cardiovascular diseases, respiratory disorders, and infectious illnesses require rapid and accurate diagnostic testing for timely clinical decision-making and effective disease management. The growing aging population, increasing healthcare utilization, and rising demand for decentralized healthcare are further accelerating market growth. As a result, healthcare providers are increasingly adopting POC diagnostic solutions to enable faster diagnosis, reduce turnaround times, and improve patient outcomes. Furthermore, continuous advancements in portable diagnostic technologies, increasing adoption of home-based testing, and the integration of digital health and connectivity features are expanding the application of POC diagnostics across hospitals, clinics, and community healthcare settings.
KEY TAKEAWAYS
-
MARKET SNAPSHOT:
Base Year Market Size (2025): USD 19.38 Billion
Current Market Size (2026): USD 20.63 Billion
Forecast Market Size (2031): USD 31.46 Billion
CAGR (2026–2031): 8.8% -
SEGMENT LEADERSHIP:
Regional Outlook: China is expected to register the highest CAGR of 11.1% during the forecast period.
Product Leader: Glucose monitoring products held 34.8% of the market in 2025.
End User Insight: Home care settings and self-testing market was valued at USD 6,936.5 million in 2025. -
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens Healthineers AG (Germany), and Becton, Dickinson and Company (BD) (US) were identified as Star Players due to their strong focus on innovation, extensive product portfolios, broad industry presence, and robust operational and financial capabilities.
Visby Medical (US), Cue Health (US), and Truvian Health (US) are among a few key startups and SMEs due to their strong product portfolio and business strategies.
Rapid improvements in healthcare infrastructure across emerging economies are significantly contributing to the growth of the point-of-care (POC) diagnostics market. Governments and private healthcare providers are expanding investments in hospitals, primary healthcare centers, diagnostic laboratories, and community health facilities to strengthen access to timely diagnostic services. These initiatives are improving healthcare delivery and encouraging the adoption of rapid, portable, and easy-to-use point-of-care diagnostic solutions. Additionally, increasing healthcare expenditure, expanding health insurance coverage, and ongoing digital health initiatives are supporting broader access to diagnostic testing across urban and rural settings. The growing emphasis on early disease detection, decentralized healthcare delivery, and improved patient outcomes is driving the integration of point-of-care diagnostics into routine clinical practice.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The point-of-care diagnostics market is evolving from conventional laboratory-based testing toward rapid, decentralized, and patient-centric diagnostic solutions that enable faster clinical decision-making across hospitals, clinics, home care, and remote settings. Rising demand for early disease detection, immediate test results, and accessible healthcare is driving the adoption of portable, user-friendly, and minimally invasive diagnostic devices. Advances in digital health technologies, AI-enabled diagnostics, smartphone connectivity, and cloud-based data management are transforming point-of-care testing by improving accuracy, efficiency, and real-time clinical insights. As healthcare providers increasingly prioritize timely diagnosis, personalized treatment, and decentralized care delivery, manufacturers are focusing on compact platforms, multiplex testing capabilities, strategic collaborations, and integrated digital ecosystems. The growing shift toward home-based testing, remote patient management, and connected healthcare infrastructure is further accelerating innovation and expanding the adoption of point-of-care diagnostics worldwide.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Rising prevalence of chronic and infectious diseases
-
Increasing demand for rapid diagnosis and immediate clinical decision-making
Level
-
Stringent regulatory requirements for diagnostic device approval
-
High costs associated with advanced POC diagnostic technologies
Level
-
Growing demand for home-based and decentralized diagnostic testing
-
Expansion of AI-enabled and digital POC diagnostic solutions
Level
-
Pricing pressure from low-cost and conventional lab testing
-
Limited healthcare infrastructure and skilled personnel in developing regions
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Rising prevalence of chronic and infectious diseases
The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, cancer, and respiratory diseases, along with the growing burden of infectious diseases, is a major driver for the point-of-care diagnostics market. Patients with these conditions require rapid and frequent diagnostic testing for early detection, disease management, and timely treatment decisions. The rising demand for decentralized healthcare, coupled with an aging population and increasing healthcare expenditures, is accelerating the adoption of point-of-care diagnostic solutions. Additionally, healthcare providers are increasingly utilizing rapid diagnostic tests to improve clinical outcomes, reduce hospital stays, and enhance patient convenience, further supporting market growth.
Restraint: Stringent regulatory requirements for diagnostic device approval
One of the major restraints in the POC diagnostics market is the stringent regulatory approval process for diagnostic devices. Manufacturers must comply with rigorous clinical validation, quality assurance, and performance standards before commercialization, which increases development costs and extends product launch timelines. Variations in regulatory requirements across different countries further complicate global market entry. As a result, these regulatory challenges can delay innovation and limit the availability of new point-of-care diagnostic technologies.
Opportunity: Growing demand for home-based and decentralized diagnostic testing
The increasing shift toward home-based healthcare and decentralized testing presents a significant opportunity in this market. Patients and healthcare providers are increasingly adopting portable diagnostic devices that deliver rapid and accurate results outside traditional laboratory settings. The expansion of telehealth services, digital health platforms, and connected diagnostic solutions is further supporting this trend by enabling remote disease monitoring and timely clinical intervention. Continuous advancements in portable testing platforms, smartphone-enabled diagnostics, and AI-assisted interpretation are expected to create substantial growth opportunities for market participants.
Challenge: Pricing pressure from low-cost and conventional laboratory testing
The widespread availability of low-cost laboratory testing and affordable diagnostic alternatives presents a key challenge for manufacturers of point-of-care diagnostic devices. Many healthcare providers continue to rely on centralized laboratory testing due to established workflows, economies of scale, and lower per-test costs. In price-sensitive markets, budget constraints may limit the adoption of advanced point-of-care diagnostic systems despite their clinical advantages. Additionally, manufacturers face increasing pressure to offer high-performance diagnostic solutions at competitive prices while maintaining quality, regulatory compliance, and continuous product innovation.
POINT OF CARE DIAGNOSTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Develops a broad portfolio of point-of-care diagnostic solutions, including rapid infectious disease testing, cardiac biomarkers, blood glucose monitoring, and handheld diagnostic analyzers for hospitals, clinics, and home care settings. | Enables rapid diagnosis, supports timely clinical decision-making, improves patient outcomes, and reduces turnaround time in emergency and primary care settings. |
 |
Provides point-of-care diagnostic systems for blood glucose monitoring, coagulation testing, infectious diseases, and molecular diagnostics, supporting hospitals, laboratories, and decentralized healthcare environments. | Delivers accurate and reliable diagnostic results, enhances disease management, improves workflow efficiency, and facilitates faster treatment decisions. |
 |
Offers molecular point-of-care diagnostic platforms for rapid detection of infectious diseases, antimicrobial resistance, and critical healthcare conditions using automated PCR technologies. | Enables highly accurate and rapid molecular testing, reduces laboratory turnaround time, supports infection control, and improves patient management. |
 |
Provides point-of-care diagnostic analyzers for blood gas, cardiac markers, coagulation, and clinical chemistry testing across emergency departments, intensive care units, and outpatient facilities. | Improves diagnostic efficiency, delivers fast and precise test results, supports critical care decision-making, and enhances operational productivity. |
 |
Manufactures rapid point-of-care diagnostic solutions for respiratory infections, COVID-19, influenza, strep, and immunoassay testing for physician offices, urgent care centers, and hospitals. | Supports quick disease detection, enables immediate treatment decisions, improves patient throughput, and enhances healthcare accessibility through decentralized testing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The ecosystem of the POC diagnostics market comprises diagnostic device manufacturers, reagent and consumable suppliers, software and connectivity providers, contract development and manufacturing organizations (CDMOs), distributors, research institutions, regulatory bodies, and healthcare providers. The market includes rapid diagnostic solutions such as molecular diagnostics, immunoassays, blood glucose monitoring systems, blood gas analyzers, cardiac biomarker tests, coagulation analyzers, and infectious disease testing platforms, supported by portable analyzers, digital health platforms, and data management software. Manufacturers focus on product innovation, assay development, regulatory approvals, and commercialization, while distributors ensure product availability across hospitals, clinics, diagnostic laboratories, pharmacies, urgent care centers, ambulatory care facilities, and home healthcare settings. The ecosystem is further strengthened by advancements in AI-enabled diagnostics, connectivity solutions, and multiplex testing, with government agencies, reimbursement bodies, and public health organizations driving adoption, regulatory compliance, and market expansion.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Patient Monitoring Devices Market, by Product
The glucose monitoring products segment includes blood glucose meters, test strips, lancets, continuous glucose monitoring (CGM) systems, and related accessories, accounting for a significant share of the market due to the increasing prevalence of diabetes and the growing adoption of self-monitoring and continuous glucose monitoring technologies. Other major product categories include cardiometabolic monitoring products for cardiovascular and metabolic health assessment, infectious disease testing products for rapid and laboratory-based pathogen detection, coagulation monitoring products for blood clotting analysis, pregnancy & fertility testing products for reproductive health monitoring, tumor/cancer marker testing products for oncology diagnostics, urinalysis testing products for kidney and urinary tract assessment, cholesterol testing products for lipid profiling, hematology testing products for complete blood count and related analyses, drugs-of-abuse testing products for toxicology screening, thyroid stimulating hormone (TSH) testing products for thyroid function evaluation, and fecal occult testing products for colorectal disease screening. The increasing demand for point-of-care diagnostics, preventive healthcare, home-based testing solutions, and technological advancements in diagnostic devices is further driving the growth of the diagnostic testing products market.
Patient Monitoring Devices Market, by End User
The hospitals, critical care centers, and urgent care centers segment holds a significant market share due to the high demand for rapid diagnostic testing and timely clinical decision-making. Clinical laboratories remain key end users for routine and specialized diagnostic testing, while ambulatory care facilities and physician offices are increasingly adopting point-of-care diagnostics to improve patient management and reduce turnaround time. The home care settings & self-testing segment is witnessing strong growth, driven by the rising adoption of self-testing kits, increasing prevalence of chronic diseases, and growing preference for convenient home-based healthcare. Other end users include retail clinics, community health centers, and research institutions.
REGION
Healthcare Infrastructure Expansion Driving Growth in the Asia Pacific Point-of-Care Diagnostics Market
The POC diagnostics market across the Asia Pacific is rapidly evolving, driven by economic growth, increasing healthcare expenditure, and a stronger government focus on improving access to timely disease diagnosis. Countries such as India, China, and Indonesia are investing significantly in strengthening primary healthcare infrastructure, expanding diagnostic capabilities, and improving access to decentralized testing services. The establishment of community health centers, rural clinics, and modern hospitals is increasing the adoption of point-of-care diagnostic technologies, enabling rapid testing for infectious diseases, chronic conditions, and emergency care. Additionally, private healthcare providers are increasingly investing in digital diagnostics, connected testing platforms, and integrated healthcare solutions to enhance clinical decision-making and patient outcomes. With continued healthcare infrastructure development and growing emphasis on early disease detection, the procurement of point-of-care diagnostic products such as blood glucose meters, rapid diagnostic tests (RDTs), HbA1c analyzers, cardiac marker testing systems, blood gas analyzers, and handheld molecular diagnostic devices is increasing, making healthcare infrastructure expansion a key driver of growth for the Asia Pacific point-of-care diagnostics market.
POINT OF CARE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX
In the point-of-care diagnostics market, Abbott (Star Player) leads with its comprehensive portfolio of rapid diagnostic solutions and strong global presence, while EKF Diagnostics (Emerging Leader) is strengthening its position through innovation in near-patient testing technologies and specialized point-of-care diagnostic solutions.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Abbott
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- QuidelOrtho Corporation
- Danaher
- Becton, Dickinson, and Company
- Thermo Fisher Scientific, Inc.
- bioMérieux
- EKF Diagnostics
- QIAGEN
- Werfen S.A
- OraSure Technologies
- Trinity Biotech
- Grifols S.A
- Nova Biomedical
- Sekisui Diagnostics
- Trividia Health
- Sysmex Corporation
- HemoCue
- Bio-Rad Laboratories
- Chembio Diagnostics
- Johnson & Johnson
- LifeScan
- Ascensia Diabetes Care
- ARKRAY
- Sinocare
- Wondfo Biotech
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size Value in 2025 (Value) | USD 19.38 Billion |
| Market Forecast in 2026 (Value) | USD 20.63 Billion |
| Market Forecast in 2031 (Value) | USD 31.46 Billion |
| Growth Rate | CAGR of 8.8% from 2026-2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD BN), Volume (Thousand Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America and Middle East & Africa |
WHAT IS IN IT FOR YOU: POINT OF CARE DIAGNOSTICS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Comparative analysis of point-of-care diagnostic technologies by product type, including glucose monitoring systems, infectious disease testing kits, cardiac biomarker tests, blood gas & electrolyte analyzers, coagulation testing devices, pregnancy & fertility tests, urinalysis, HbA1c analyzers, molecular diagnostics, rapid antigen tests, and multiplex diagnostic platforms, along with evaluation across hospitals, emergency departments, physician offices, clinics, pharmacies, homecare, and decentralized healthcare settings. | Assessment of diagnostic performance through parameters such as sensitivity, specificity, turnaround time, portability, ease of use, connectivity, CLIA-waived capabilities, AI integration, workflow efficiency, cost-effectiveness, and regulatory compliance to support optimal product selection and improved clinical outcomes. |
| Company Information | Detailed profiles of leading global and regional point-of-care diagnostics manufacturers, including Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher (Cepheid, Beckman Coulter), bioMérieux, BD, QuidelOrtho, Thermo Fisher Scientific, Sysmex, EKF Diagnostics, and Nova Biomedical, covering product portfolios, diagnostic technologies, strategic initiatives, geographic presence, partnerships, regulatory approvals, and recent product developments. | Competitive benchmarking across key players highlighting positioning by technological innovation, test menu breadth, molecular diagnostics capabilities, digital connectivity, pricing strategies, distribution networks, manufacturing capacity, and focus areas such as infectious diseases, chronic disease management, emergency care, and home diagnostics. |
| Geographic Analysis | In-depth regional assessment of the global point-of-care diagnostics market across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with analysis of healthcare infrastructure, disease burden, diagnostic accessibility, reimbursement landscape, regulatory environment, and decentralized testing adoption trends. | Country-level market sizing, CAGR forecasts, epidemiological analysis, healthcare expenditure trends, regulatory landscape assessment, diagnostic penetration rates, reimbursement policies, and demand outlook across major markets such as the US, Germany, UK, China, India, Japan, Brazil, and GCC countries. |
RECENT DEVELOPMENTS
- January 2025 : Abbott continued expanding its Point of Care diagnostics portfolio with rapid diagnostic solutions for cardiometabolic, infectious disease, and emergency care applications.
- May 2025 : Roche expanded its cobas liat point-of-care PCR testing portfolio to strengthen rapid decentralized infectious disease diagnostics.
- February 2025 : Siemens Healthineers advanced its point-of-care diagnostics strategy by enhancing digitalized near-patient testing and workflow efficiency across healthcare settings.
- June 2025 : QuidelOrtho announced the planned acquisition of LEX Diagnostics to strengthen its rapid point-of-care molecular diagnostics portfolio.
- April 2025 : Danaher continued expanding its Cepheid and Radiometer businesses to strengthen rapid molecular and point-of-care diagnostic testing capabilities.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The study involved major activities to estimate the current market size of the Point of Care diagnostics market. Exhaustive secondary research was conducted to gather information on the market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the POC diagnostics market.
Secondary Research
This research study involved the extensive use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and Companies House documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the POC diagnostics market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/Managing Directors, Marketing Heads/Directors, Sales Directors, Marketing/Sales Managers, Regional/Area Sales Managers, Export/Import Heads/Managers, and Other Market-Related Personnel from various companies and organizations operating in the POC diagnostics market. Primary sources from the demand side included Law Enforcement Agencies, Vice Presidents, C-level Executives, Department Heads, Enterprises, Individuals, Supply Management Teams of Hospitals, Clinic Personnel, and Laboratory Technicians.
Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Other primary roles include sales, marketing, and product management.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the POC diagnostics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The entire market was split into two segments when the market size was determined. Data triangulation and market breakdown were used as needed to complete the market engineering process and derive precise statistics for all segments.
Approach for deriving the market size and estimating market growth:
Using secondary data from paid and unpaid sources, the market rankings for the major players were determined through a thorough analysis of their POC diagnostic sales. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Point-of-care (POC) diagnostics refers to diagnostic testing performed at or near the patient's location, delivering rapid and accurate results to support immediate clinical decision-making. The market includes products such as blood glucose monitoring systems, infectious disease tests, cardiac biomarker assays, coagulation testing, blood gas and electrolyte analyzers, molecular diagnostics, pregnancy and fertility tests, urinalysis, and other rapid diagnostic solutions, serving hospitals, clinical laboratories, physician offices, ambulatory care facilities, retail clinics, pharmacies, and home healthcare settings.
Key Stakeholders
- Diagnostic device manufacturers
- Reagent and consumable suppliers
- Hospitals and clinical laboratories
- Physician offices and ambulatory care centers
- Pharmacies and home healthcare providers
- Medical device distributors
- Regulatory authorities
- Government and public health agencies
- Research organizations
- Healthcare IT providers
Report Objectives
- To describe, analyze, and forecast the POC diagnostics market, by product, sample, mode of purchase, technology, end user, and region
- To describe and forecast the POC diagnostics market for key regions, namely, North America, Europe, the Asia Pacific, Latin America and Middle East, and Africa
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the POC diagnostics market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies2 in the POC diagnostics market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the POC diagnostics market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific POC diagnostics market into Vietnam, New Zealand, and other markets.
- Further breakdown of the Rest of Latin America POC diagnostics market into Colombia, Chile, Ecuador, and others.
- Further breakdown of the Rest of Europe POC diagnostics market into Belgium, Russia, the Netherlands, Switzerland, and others.
Key Questions Addressed by the Report
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Point of Care Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
- Canada Point of Care Diagnostics Market
- US Point of Care Diagnostics Market
- Germany Point of Care Diagnostics Market
- France Point of Care Diagnostics Market
- UK Point of Care Diagnostics Market
- Italy Point of Care Diagnostics Market
- Spain Point of Care Diagnostics Market
- China Point of Care Diagnostics Market
- Japan Point of Care Diagnostics Market
- India Point of Care Diagnostics Market
- Australia Point of Care Diagnostics Market
- South Korea Point of Care Diagnostics Market
- Brazil Point of Care Diagnostics Market
- Mexico Point of Care Diagnostics Market
Growth opportunities and latent adjacency in Point of Care Diagnostics Market
Dennis
Jul, 2026
After reviewing the Point of Care Diagnostics Market report, I found the breakdown of decentralized testing adoption across emergency care, home diagnostics, and chronic disease monitoring particularly useful for evaluating near-term commercialization opportunities..
Jerry
Jul, 2026
I filled out the form to better understand how the Point of Care Diagnostics Market is evolving with rapid antigen technologies and portable molecular platforms, especially in regions where lab infrastructure remains limited..
Tyler
Jul, 2026
The insights on reimbursement trends, device miniaturization, and competitive positioning in the Point of Care Diagnostics Market gave me a clearer perspective on how manufacturers are adapting their product strategies for faster clinical decision-making..